Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for VASC
+0.44 (1.15%)
Real-time:   12:30PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 38.06 - 38.61
52 week 24.34 - 40.33
Open 38.28
Vol / Avg. 25,436.00/161,321.00
Mkt cap 667.55M
P/E 86.71
Div/yield     -
EPS 0.45
Shares 17.37M
Beta 0.62
Inst. own 79%
Aug 23, 2016
Vascular Solutions Inc at CFA Society of Minnesota's InvestMNt Conference Add to calendar
Aug 10, 2016
Vascular Solutions Inc at Canaccord Genuity Growth Conference Add to calendar
Jul 19, 2016
Q2 2016 Vascular Solutions Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 9, 2016
Vascular Solutions Inc at Citi Small and Mid Cap Conference Add to calendar
Apr 29, 2016
Vascular Solutions Inc Annual Shareholders Meeting (Estimated)
Apr 29, 2016
Vascular Solutions Inc Annual Shareholders Meeting
Apr 25, 2016
Q1 2016 Vascular Solutions Inc Earnings Call - Webcast
Apr 25, 2016
Q1 2016 Vascular Solutions Inc Earnings Release
Apr 12, 2016
Vascular Solutions Inc at Needham Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -0.65% 7.11%
Operating margin -2.26% 9.24%
EBITD margin - 13.31%
Return on average assets -0.72% 7.71%
Return on average equity -0.80% 8.67%
Employees 568 -
CDP Score - -


6464 Sycamore Ct N
MAPLE GROVE, MN 55369-6032
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to the market for treating coronary and peripheral vascular disease. The Company's product line consists of devices and services that are sold to interventional cardiologists, interventional radiologists, electrophysiologists and vein practices around the world. Its products include GuideLiner catheters, Pronto catheters, Vein catheter reprocessing, Micro-introducer kits, Hemostatic patches, Radial access products, Langston catheters and D-Stat Flowable hemostat. The Company's product portfolio includes a spectrum of over 90 products consisting of approximately 900 stock keeping units (SKUs) covering an array of blood clotting devices, extraction catheters, access catheters, guide extension catheters, micro-introducer kits, guidewires, snare and retrieval devices, a reprocessing service for radiofrequency catheters and a laser and procedure kits for the treatment of varicose veins.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Howard C. Root Chief Executive Officer and Director
Age: 55
Bio & Compensation  - Reuters
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - International Sales
Age: 63
Bio & Compensation  - Reuters
Brent Binkowski Senior Vice President - Operations
Age: 47
Bio & Compensation  - Reuters
Chad Kugler Senior Vice President - Research and Development
Age: 44
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 41
Bio & Compensation  - Reuters
Martin J. Emerson Independent Director
Bio & Compensation  - Reuters
Richard W. Kramp Independent Director
Age: 69
Bio & Compensation  - Reuters
Richard J. Nigon Independent Director
Age: 67
Bio & Compensation  - Reuters